Trial Profile
Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Valsartan
- Indications Angina pectoris; Atherosclerosis; Hypertension
- Focus Therapeutic Use
- Acronyms OVATION
- 07 Nov 2012 Results in 71 patients presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 04 Mar 2011 New trial record
- 01 Oct 2010 Primary endpoint 'Plaque-volume' has not been met.